Research too weak to recommend cannabis for palliative care

Embargoed until: Publicly released: 2022-06-14 10:41

New Zealand

Photo by Jeff W on Unsplash

Scientists have pulled together 52 studies on the use of medicinal cannabis in end-of-life care, finding the quality of evidence was 'very low' or 'low' for all studies. Some positive effects were seen for things like pain, nausea, and fatigue in patients with cancer, dementia, and AIDS, however, the researchers say more studies need to produce high-quality evidence before they can make any conclusions on its use in palliative care.

Media release

From:

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Elsevier, Web page

Journal/
conference: Journal of Pain and Symptom Management

Research:Paper

Organisation/s: Medical Research Institute of New Zealand, Capital & Coast DHB

Funder: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The MRINZ receives Independent Research Organisation funding from the Health Research Council of New Zealand.

Media Contact/s

Contact details are only visible to registered journalists.